State University of New York - Upstate Medical University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York - Upstate Medical University sits in the top decile of US sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count).
State University of New York - Upstate Medical University: 113 sponsored US clinical trials, 8 recruiting.
State University of New York - Upstate Medical University sponsors 113 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 75 completed. 15 of these trials are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 2 trials.
Top-decile sponsor footprint
State University of New York - Upstate Medical University ranks in the top decile of sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
75 of 103 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
113 total, page 3 of 3
Biomechanical Evaluation of Wrist Ligament Injuries: Diagnostic Tool to Detect Wrist Instability
NCT00657072
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
NCT00145847
Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
NCT00634816
Huntsman Biopsy Study
NCT00615329
Use of Radiostereometric Analysis Beads (RSA) to Measure Motion in the Spine, Following Lumbar Spinal Surgery
NCT00152152
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
NCT00145704
Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
NCT00615628
The Role of Impact Activity in Peripubertal Bone Accrual
NCT00619047
Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities
NCT00639535
A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
NCT00629434
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003555
Improve Nuclear Medicine Heart Imaging, Compare MRI Results With Single Photon Emission Computed Tomography Imaging
NCT00639704
Evaluation of the MRI in Measuring the Cardiac Chambers and Thoracic Great Vessels
NCT00638664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the State University of New York - Upstate Medical University pipeline
8 recruiting of 113 indexed (7% open); 75 completed (66%).
Phase mix: 15 late (III/IV) vs 21 early (I/II) (balanced across stages).
Top condition: Stroke (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York - Upstate Medical University: open-pipeline peers nationwide
Peers matched on 113 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
State University of New York - Upstate Medical University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 113 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Bristol-Myers Squibb · 7% recruiting · 1,025 trials
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Kaiser Permanente · 7% recruiting · 294 trials
Related
What to do with this State University of New York - Upstate Medical University page
113 registered trials is a research-attention snapshot, not an endorsement of State University of New York - Upstate Medical University or any single study.
- 8 of State University of New York - Upstate Medical University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition State University of New York - Upstate Medical University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. State University of New York - Upstate Medical University pipeline card: 113 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.